Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rakeeb Kureshi

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Advances in Experimental Medicine and Biology|October 20, 2019
Structural Basis for Signaling Through Shared Common γ Chain CytokinesHuilin Yang, Rakeeb Kureshi, Jamie B Spangler
Immunotherapy Advances|July 18, 2023
Blockade of innate inflammatory cytokines TNF<b>α</b>, IL-1<b>β</b>, or IL-6 overcomes virotherapy-induced cancer equilibrium to promote tumor regressionMichael J Walsh, Lestat R Ali, Patrick Lenehan, et al.
Cell Reports|March 7, 2023
IFNγ is a central node of cancer immune equilibriumMichael J Walsh, Courtney T Stump, Rakeeb Kureshi, et al.
Cellular and Molecular Bioengineering|November 13, 2020
Structure-Guided Molecular Engineering of a Vascular Endothelial Growth Factor Antagonist to Treat Retinal DiseasesRakeeb Kureshi, Angela Zhu, Jikui Shen, et al.
Science Advances|November 24, 2023
DGKα/ζ inhibition lowers the TCR affinity threshold and potentiates antitumor immunityRakeeb Kureshi, Elisa Bello, Courtney T S Kureshi, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2021
Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeuticsDhiraj Kumar, Akhilesh Mishra, Ala Lisok, et al.
Cell Chemical Biology|March 28, 2024
Multiparatopic antibodies induce targeted downregulation of programmed death-ligand 1Seth D Ludwig, Bunyarit Meksiriporn, Jiacheng Tan, et al.
Cancer Cell|May 8, 2026
Dendritic cell redundancy enables priming of anti-tumor CD4<sup>+</sup> T cells in pancreatic cancerCourtney T S Kureshi, Michael J Walsh, Rakeeb Kureshi, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Potent antitumor activity of a designed interleukin-21 mimicJung-Ho Chun, Birkley S Lim, Suyasha Roy, et al.
Science Immunology|September 26, 2025
Design of a potent interleukin-21 mimic for cancer immunotherapyJung-Ho Chun, Birkley S Lim, Suyasha Roy, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Advances in Experimental Medicine and Biology|October 20, 2019
Structural Basis for Signaling Through Shared Common γ Chain CytokinesHuilin Yang, Rakeeb Kureshi, Jamie B Spangler
Immunotherapy Advances|July 18, 2023
Blockade of innate inflammatory cytokines TNF<b>α</b>, IL-1<b>β</b>, or IL-6 overcomes virotherapy-induced cancer equilibrium to promote tumor regressionMichael J Walsh, Lestat R Ali, Patrick Lenehan, et al.
Cell Reports|March 7, 2023
IFNγ is a central node of cancer immune equilibriumMichael J Walsh, Courtney T Stump, Rakeeb Kureshi, et al.
Cellular and Molecular Bioengineering|November 13, 2020
Structure-Guided Molecular Engineering of a Vascular Endothelial Growth Factor Antagonist to Treat Retinal DiseasesRakeeb Kureshi, Angela Zhu, Jikui Shen, et al.
Science Advances|November 24, 2023
DGKα/ζ inhibition lowers the TCR affinity threshold and potentiates antitumor immunityRakeeb Kureshi, Elisa Bello, Courtney T S Kureshi, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2021
Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeuticsDhiraj Kumar, Akhilesh Mishra, Ala Lisok, et al.
Cell Chemical Biology|March 28, 2024
Multiparatopic antibodies induce targeted downregulation of programmed death-ligand 1Seth D Ludwig, Bunyarit Meksiriporn, Jiacheng Tan, et al.
Cancer Cell|May 8, 2026
Dendritic cell redundancy enables priming of anti-tumor CD4<sup>+</sup> T cells in pancreatic cancerCourtney T S Kureshi, Michael J Walsh, Rakeeb Kureshi, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Potent antitumor activity of a designed interleukin-21 mimicJung-Ho Chun, Birkley S Lim, Suyasha Roy, et al.
Science Immunology|September 26, 2025
Design of a potent interleukin-21 mimic for cancer immunotherapyJung-Ho Chun, Birkley S Lim, Suyasha Roy, et al.
Pageof 2